Idiopathic Restless Legs Syndrome Clinical Trial
Official title:
An Open-label Extension Trial to Investigate the Safety and Tolerability of Long-term Treatment With Transdermal Rotigotine in Subjects With Idiopathic Restless Legs Syndrome
This is a multicenter, open-label trial to assess safety and tolerability of rotigotine in subjects with idiopathic Restless Legs Syndrome (RLS), administered at an optimal dose for up to 1 year in subjects who previously participated in SP790 (6-month pivotal trial) or SP794 (sleep lab trial). Subjects who successfully completed the Maintenance Period and the Taper Period of SP790 or SP794 are allowed to enroll in this trial.
n/a
Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00390689 -
A Randomised, Comparing Fixed Doses of Pramipexole to Investigate the Efficacy and Safety in Patients With RLS.
|
Phase 3 | |
| Completed |
NCT01113710 -
Non-interventional Study (NIS) in Patients With Restless Legs Syndrome in Daily Practise
|
N/A | |
| Completed |
NCT00666965 -
A Placebo-Controlled Study for SPM 962 in Restless Legs Syndrome (RLS) Patients
|
Phase 2 | |
| Completed |
NCT01084551 -
Study of SPM 962 in Patients With Restless Legs Syndrome (RLS)
|
Phase 3 | |
| Completed |
NCT00806026 -
Long Term Study Of Pregabalin In Idiopathic Restless Legs Syndrome Patients
|
Phase 3 | |
| Completed |
NCT01562743 -
A Long-Term Extension Trial From Late Phase II of SPM 962 in Patients With Restless Legs Syndrome
|
Phase 2 |